REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $5,000 | +66.7% | 2,446 | -0.1% | 0.00% | – |
Q2 2016 | $3,000 | -93.2% | 2,448 | -94.7% | 0.00% | – |
Q1 2016 | $44,000 | -42.9% | 46,179 | -27.4% | 0.00% | – |
Q4 2015 | $77,000 | -69.3% | 63,639 | +87.4% | 0.00% | – |
Q3 2015 | $251,000 | -73.7% | 33,951 | -74.6% | 0.00% | -100.0% |
Q2 2015 | $956,000 | +44.2% | 133,828 | +73.0% | 0.00% | – |
Q1 2015 | $663,000 | +205.5% | 77,335 | +252.2% | 0.00% | – |
Q4 2014 | $217,000 | +7.4% | 21,959 | +6.0% | 0.00% | – |
Q3 2014 | $202,000 | -26.8% | 20,709 | +29.0% | 0.00% | – |
Q2 2014 | $276,000 | -64.4% | 16,051 | -65.1% | 0.00% | -100.0% |
Q1 2014 | $775,000 | -34.5% | 46,010 | -29.9% | 0.00% | 0.0% |
Q4 2013 | $1,184,000 | +13.8% | 65,665 | +34.5% | 0.00% | 0.0% |
Q3 2013 | $1,040,000 | – | 48,834 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,132,367 | $9,727,000 | 2.05% |
RTW INVESTMENTS, LP | 229,364 | $1,970,000 | 0.89% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 361,300 | $3,104,000 | 0.85% |
DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,826,000 | 0.73% |
SENZAR ASSET MANAGEMENT, LLC | 244,006 | $2,096,000 | 0.51% |
GENERAL AMERICAN INVESTORS CO INC | 508,375 | $4,367,000 | 0.36% |
CQS Cayman LP | 700,000 | $6,013,000 | 0.28% |
Rotella Capital Management, Inc. | 20,800 | $179,000 | 0.15% |
Baker Brothers Advisors | 2,000,000 | $17,180,000 | 0.14% |
Gruss Capital Management LP | 304,000 | $2,611,000 | 0.11% |